Carsten Rudolph
Managing Director & Chief Executive Officer Ethris GmbH
Carsten Rudolph, PhD is a co-founder of Ethris and the lead inventor of its SNIM® RNA Technology. His deep expertise is delivering mRNA specifically to the lungs. He is the inventor of 15 patents/applications and has authored more than 120 scientific publications. Carsten is affiliated with the Dr. von Haunersche Children’s Hospital, part of Ludwig Maximilian University in Munich. He obtained his pharmaceutical degree from the Freie Universität Berlin.
Seminars
Tuesday 15th September 2026
Restoring Antiviral Defence With Interferon Lambda to Prevent Virus Driven Respiratory Exacerbations
11:00 am
- How inhaled mRNA delivery of interferon lambda restores epithelial host resistance to reduce virus driven exacerbations in chronic lung disease
- Why targeting interferon lambda upstream of inflammation offers a new preventative strategy beyond bronchodilators biologics and steroids
- What early clinical data show including phase 2a asthma results demonstrating safety, target engagement and the potential to translate this approach into COPD
